1.5M
Downloads
1124
Episodes
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes
Oct 31, 2025
Oct 31, 2025
59 min
Stay plugged into the conversations, discoveries, and breakthroughs moving rheumatology forward. Real updates. Real context. For clinicians who never stop learning.
Oct 31, 2025
Oct 31, 2025
4 min
Dr. Jack Cush recaps ACR2025 with suggestions on how to best learn ACR25 content from RheumNow.com and our Videos and podcasts.
Oct 30, 2025
Oct 30, 2025
Oct 30, 2025
8 min
Restoring B Cell Compartments with CAR T: Molecular Data is Here
CAR-T: The Future
Oct 29, 2025
Oct 29, 2025
27 min
Revised Classification Criteria in axSpA https://www.youtube.com/watch?v=voFJrQo1ANU
NSAID Addition Helps the Spine but not the Hips https://www.youtube.com/watch?v=wTKMC1MTwpE
Biomarker Discovery in axSpA https://www.youtube.com/watch?v=X8Sc_3oBSVA
Sexual Function in axSpA https://www.youtube.com/watch?v=r4_Nsh7e_oo
Coping Strategies in axSpA https://www.youtube.com/watch?v=z9KdNuOu4nI
"ROC-SpA Study" https://www.youtube.com/watch?v=kIEN39XRsSM
Why do patients stay in clinical trials? https://www.youtube.com/watch?v=pVIBoN0jO2o
What to do after first TNR failure in axSpA? https://www.youtube.com/watch?v=PVSyq_Y5-PE
Oct 29, 2025
Oct 29, 2025
15 min
ILD in Patients with Connective Tissue Disease
Fiber and Methotrexate
RA ILD Prediction: simple as a dipstick?
"Leftover Pain in Inflammatory Arthritis"
Oct 29, 2025
Oct 29, 2025
17 min
From Pain to Wellness in PsA
Secukinumab vs Ustekinumab in PsA
Izokibep: still enthused about enthesitis?
Using Digital Apps to Modify Pain in axSpA
Oct 29, 2025
Oct 29, 2025
25 min
"ROC-SpA Study"
Secukinumab vs Ustekinumab in PsA
RA ILD Prediction: simple as a dipstick?
Sjogren's Disease: PROs as a Filter for Precision Medicine
Why do patients stay in clinical trials?
Using Digital Apps to Modify Pain in axSpA
IgG4: Rare but Treatable!
Oct 29, 2025
Oct 29, 2025
42 min
From Pain to Wellness in PsA
IL-2 Therapy in SLE? Maybe
Sexual Function in axSpA
"Fact or Fiction: Trinetics Research at ACR"
CD1/BCMA Dual Targeting: One too many targets in SLE
Hydroxychloroquine Blood Levels
The Great Debate: AI in Rheumatology
Coping Strategies in axSpA
"What to do After First TNR Failure in axSpA"
Oct 29, 2025
Oct 29, 2025
34 min
Join panelists Drs. Brian Jaros, Akhil Sood and Michael Putman as they recap highlights from Day 4, the final day of the 2025 ACR Convergence meeting in Chicago.